Carrie D. Wolinetz, PhD; Francis S. Collins, MD, PhD
free access
JAMA. 2020;324(11):1027-1028. doi:10.1001/jama.2020.15936
In this Viewpoint, the NIH director and acting chief of staff discuss how Henrietta Lacks’ cervical cancer cells (HeLa) were used without her consent to create an immortal cell line used widely in modern medical research, and argue for development of policies to prevent unauthorized use of biological specimens to prevent the same thing from happening again.
Lisa A. Grohskopf, MD, MPH; Leandris C. Liburd, PhD, MPH; Robert R. Redfield, MD
free access
has active quiz
has multimedia
has audio
JAMA. 2020;324(11):1029-1030. doi:10.1001/jama.2020.15845
In this Viewpoint, CDC scientists discuss the public health urgency of increasing influenza vaccination uptake early in the 2020-2021 season to ameliorate the threat to patients and hospitals of overlapping outbreaks, and urges clinicians to strongly recommend the vaccine and administer it to patients whenever and wherever possible.
-
Conversations with Dr Bauchner:
Coronavirus Update From the CDC – August 20, 2020
-
Editorial
Vaccine Distribution—Equity Left Behind?
Muriel Jean-Jacques, MD, MAPP; Howard Bauchner, MD
-
Conversations with Dr Bauchner:
Who Gets Coronavirus Vaccine First?
-
Conversations with Dr Bauchner:
Prioritizing Racial and Ethnic Minority Populations for Coronavirus Vaccination
-
Conversations with Dr Bauchner:
Coronavirus Vaccine Update From the CDC With Nancy E. Messonnier, MD
Emily A. Wang, MD, MAS; Jonathan Zenilman, MD, PhD; Lauren Brinkley-Rubinstein, PhD
free access
has active quiz
JAMA. 2020;324(11):1031-1032. doi:10.1001/jama.2020.15589
This Viewpoint discusses the importance of studying coronavirus disease 2019 (COVID-19) vaccine candidates in prisoners, and proposes a framework for considering how to include them safely, ethically, and without coercion in future phase 3 vaccine trials.
-
Editorial
Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine
Howard Bauchner, MD; Preeti N. Malani, MD, MSJ; Joshua Sharfstein, MD
-
Conversations with Dr Bauchner:
COVID-19 Vaccine Approval and the FDA
-
Conversations with Dr Bauchner:
Coronavirus Update With Michael T. Osterholm, PhD, MPH
-
Conversations with Dr Bauchner:
Coronavirus Q&A With Anthony Fauci, MD – September 25, 2020
-
Conversations with Dr Bauchner:
Coronavirus Update With Anthony Fauci - October 28, 2020
-
Conversations with Dr Bauchner:
Coronavirus Vaccine Update With Anthony Fauci
Catherine R. Lucey, MD; S. Claiborne Johnston, MD, PhD
free access
has active quiz
has audio
JAMA. 2020;324(11):1033-1034. doi:10.1001/jama.2020.14136
This Viewpoint discusses the ways medical schools adapted to the coronavirus disease 2019 (COVID-19) pandemic, allowing students to be part of the public health response, adapting curricula to educational opportunities, and modernizing means of instruction without losing time or compromising standards.
-
Conversations with Dr Bauchner:
The Transformational Effects of COVID-19 on Medical Education
Justin A. Grischkan, MD; Ari B. Friedman, MD, PhD; Amitabh Chandra, PhD
JAMA. 2020;324(11):1035-1036. doi:10.1001/jama.2020.15480
This Viewpoint challenges US hospital claims that government funding to train physicians is necessary to offset costs, maintain physician supply, and keep costs low for other payers, and proposes reforms to use the monies to target known problems, such as geographic disparities in physician workforce and inadequate primary care and public health physician supply.
Lawrence O. Gostin, JD; James G. Hodge Jr, JD, LLM; Donna E. Levin, JD
JAMA. 2020;324(11):1037-1038. doi:10.1001/jama.2020.7715
This Viewpoint discusses ways that evidence-based laws can address health disparities and halt the documented reduction of life expectancy across socioeconomic groups in the US, including through regulation of hazardous products, behavioral economic incentives, wage increases, and provision of public benefits.